The cross-sectional and longitudinal relationships between white matter hyperintensities and dementia in patients with Parkinson's disease: A retrospective analysis of 132 patients in a single center

Archives of Gerontology and Geriatrics

Volumn 62, Issue , 2016, Pages 133-137

  Lee, Seung Jae ^a   Lee, Dong Geun ^a  

^a Sejong General Hospital   (South Korea)

Author keywords

Dementia; Parkinson's disease; Postural instability; White matter hyperintensities

Indexed keywords

ADULT; AGED; COMPLICATION; CROSS-SECTIONAL STUDY; DEMENTIA; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; WHITE MATTER;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DEMENTIA; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; WHITE MATTER;

EID: 84952913995     PISSN: 01674943     EISSN: 18726976     Source Type: Journal    
DOI: 10.1016/j.archger.2015.10.006     Document Type: Article

References (35)

1. Alves G., Larsen J.P., Emre M., Wentzel-Larsen T., Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Movement Disorders 2006, 21:1123-1130.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington DC. 4th ed.
3. Bocti C., Swartz R.H., Gao F.Q., Sahlas D.J., Behl P., Black S.E. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia. Stroke 2005, 36:2126-2131.
4. Braak H., Rüb U., Jansen Steur E.N., Del Tredici K., de Vos R.A. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 2005, 64:1404-1410.
5. Brickman A.M. Contemplating Alzheimer's disease and the contribution of white matter hyperintensities. Current Neurology and Neuroscience Reports 2013, 13:415.
6. Caplan L.R., Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Archives of Neurology 1998, 55:1475-1482.
7. Debette S., Markus H.S. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010, 341:c3666.
8. Domellöf M.E., Ekman U., Forsgren L., Elgh E. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up. Acta Neurologica Scandinavica 2015, (February). 10.1111/ane.12375.
9. Gago M.F., Garrett M.C., Fonseca M.R., Rosas M.J., Simões M.F., Vieira S., et al. How do cognitive and axial motor signs correlate in Parkinson's disease? A 6-year prospective study. Journal of Neurology 2009, 256:1655-1662.
10. Gouw A.A., van der Flier W.M., van Straaten E.C., Pantoni L., Bastos-Leite A.J., Inzitari D., et al. LADIS study group: reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovascular Diseases 2008, 25:247-253.
11. Ha S.Y., Youn Y.C., Kim S., Hsiung G.Y., Ahn S.W., Shin H.W., et al. A voxel-based morphometric study of cortical gray matter volume changes in Alzheimer's disease with white matter hyperintensities. Journal of Clinical Neuroscience 2012, 19:1506-1510.
12. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery, and Psychiatry 1992, 55:181-184.
13. Kalra S., Grosset D.G., Benamer H.T. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Movement Disorders 2010, 25:149-156.
14. Kandiah N., Mak E., Ng A., Huang S., Au W.L., Sitoh Y.Y., et al. Cerebral white matter hyperintensity in Parkinson's disease: a major risk factor for mild cognitive impairment. Parkinsonism & Related Disorders 2013, 19(July (7)):680-683.
15. Kandiah N., Zainal N.H., Narasimhalu K., Chander R.J., Ng A., Mak E., et al. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease. Parkinsonism & Related Disorders 2014, 20:1203-1208.
16. Kang S.J., Choi S.H., Lee B.H., Kwon J.C., Na D.L., et al. The reliability and validity of the Korean instrumental activities of daily living (K-IADL). Journal of the Korean Neurological Association 2002, 20:8-14.
17. Kang J.H., Irwin D.J., Chen-Plotkin A.S., Siderowf A., Caspell C., Coffey C.S., et al. Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease. JAMA Neurology 2013, 70(October (10)):1277-1287.
18. Lee P.H., Hwang E.M., Hong H.S., Boo J.H., Mook-Jung I., Huh K. Effect of ischemic neuronal insults on amyloid precursor protein processing. Neurochemical Research 2006, 31:821-827.
19. Lee S.J., Kim J.S., Yoo J.Y., Song I.U., Kim B.S., Jung S.L., et al. Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Disease and Associated Disorders 2010, 24:227-233.
20. Lee S.J., Kim J.S., Chung S.W., Kim B.S., Ahn K.J., Lee K.S. White matter hyperintensities (WMH) are associated with intracranial atherosclerosis rather than extracranial atherosclerosis. Archives of Gerontology and Geriatrics 2011, 53:e129-e132.
21. Lee M.J., Seo S.W., Na D.L., Kim C., Park J.H., Kim G.H., et al. Synergistic effects of ischemia and β-amyloid burden on cognitive decline in patients with subcortical vascular mild cognitive impairment. JAMA Psychiatry 2014, 71:412-422.
22. Müller M.L., Frey K.A., Petrou M., Kotagal V., Koeppe R.A., Albin R.L., et al. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Movement Disorders 2013, 28:296-301.
23. Matsubayashi K., Okumiya K., Wada T., Osaki Y., Fujisawa M., Doi Y., et al. Postural dysregulation in systolic blood pressure is associated with worsened scoring on neurobehavioral function tests and leukoaraiosis in the older elderly living in a community. Stroke 1997, 28:2169-2173.
24. Norrving B. Evolving concept of small vessel disease through advanced brain imaging. Journal of Stroke 2015, 17:94-100.
25. Pantoni L., Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke 1997, 28:652-659.
26. Pantoni L., Basile A.M., Pracucci G., Asplund K., Bogousslavsky J., Chabriat H., et al. Impact of age-related cerebral white matter changes on the transition to disability - the LADIS study: rationale, design and methodology. Neuroepidemiology 2005, 24:51-62.
27. Park H.E., Park I.S., Oh Y.S., Yang D.W., Lee K.S., Choi H.S., et al. Subcortical whiter matter hyperintensities within the cholinergic pathways of patients with dementia and parkinsonism. Journal of Neurological Sciences 2015, 353:44-48.
28. Preston S.D., Steart P.V., Wilkinson A., Nicoll J.A., Weller R.O. Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain. Neuropathology and Applied Neurobiology 2003, 29(April (2)):106-117.
29. Rektor I., Rektorová I., Kubová D. Vascular parkinsonism - an update. Journal of Neurological Science 2006, 248:185-191.
30. Seo S.W., Lee J.M., Im K., Park J.S., Kim S.H., Kim S.T., et al. Cortical thinning related to periventricular and deep white matter hyperintensities. Neurobiology of Aging 2012, 33:1156-1167.
31. Shin J., Choi S., Lee J.E., Lee H.S., Sohn Y.H., Lee P.H. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status. Journal of Neurology, Neurosurgery, and Psychiatry 2012, 83:315-321.
32. Sunwoo M.K., Jeon S., Ham J.H., Hong J.Y., Lee J.E., Lee J.M., et al. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease. European Journal of Neurology 2014, 21. 922-e50.
33. Tullberg M., Fletcher E., DeCarli C., Mungas D., Reed B.R., Harvey D.J., et al. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004, 63:246-253.
34. Zhu K., van Hilten J.J., Marinus J. Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG. Parkinsonism & Related Disorders 2014, 20:980-985.
35. van Straaten E.C., Fazekas F., Rostrup E., Scheltens P., Schmidt R., Pantoni L., et al. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 2006, 37:836-840.